Search Results

An Interview With Sabine Steiner, MD

Dr. Steiner shares her take on current issues in femoropopliteal disease, including emerging data and ongoing research to improve results in this challenging anatomy.

After the Meta-Analysis…

By Sabine Steiner, MD, and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Panel Discussion: Endovascular Therapies for TASC C and D Femoropopliteal Disease

Prof. Ramon L. Varcoe asks Drs. Herbert D. Aronow, Darren B. Schneider, and Sabine Steiner about current evidence for treatment of TASC C and D lesions, their preferred access and approach to advanced disease, if lesion location affects decision-making, and which new therapies hold promise for treating these complex lesions.

Pipeline Report: A Look at Next-Generation SFA Technologies

A review of the recent advances in lesion crossing, atherectomy, vessel preparation, and drug delivery technologies.

By Sabine Steiner, MD, and Andrej Schmidt, MD

The Evolving PAD Patient Population: How Is It Changing?

Recognition of generational trends and their impact on decision-making and patient care.

With moderator Peter A. Schneider, MD, and panelists Joshua Beckman, MD; Sabine Steiner, MD; and Kevin Rogers, MD

Perspectives on BTK Vessel Prep

BTK versus ATK algorithms, vessel prep decision-making and device selection, impressions on the BTK vessel prep data landscape, and the impact of reimbursement on therapy selection.

With Michel Bosiers, MD; John H. Rundback, MD; Sabine Steiner, MD; and Daniel A.F. van den Heuvel, MD

Bioresorbable Stent Technology for Femoropopliteal Disease Treatment: Where Do We Stand?

Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.

By Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD

Considering the Next Horizon of CLTI Trials

With BEST-CLI and BASIL-2 now complete, physicians contemplate the next phase of CLTI trials, including areas of focus and predictions for the most clinically impactful data.

With Marianne Brodmann, MD; Kumar Madassery, MD, FSIR; Sabine Steiner, MD; Zola N’Dandu, MD, FSCAI; and Matthew Menard, MD

Ask the Experts: Repeat Revascularization in Rutherford 5/6 Patients: What Is Your Point of No Return?

Approaches to initial and repeat revascularization while considering patient preference and disease characteristics.

With Venita Chandra, MD, and Sabine Steiner, MD

Ask the Experts: What Is Your Top Tip on How to Safely and Efficiently Cross a Lower Extremity CTO?

Experts discuss their access approaches to and techniques for crossing chronic total occlusions.

With John A. Phillips, MD; Saher Sabri, MD, FSIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Sabine Steiner, MD; and Osamu Iida, MD

Peripheral Drug Delivery Devices: Where Do We Stand?

Surveying the landscape of paclitaxel and sirolimus/everolimus devices for peripheral artery disease revascularization, with commentary on advantages and disadvantages and when each might be used, treatment algorithms for above the knee, the next wave of below-the-knee trial data, and the role of bioresorbables.

With Brian DeRubertis, MD; Andrew Holden, MD; Peter A. Schneider, MD; Sabine Steiner, MD; and Edward T.C. Choke, MBBS, FRCS, PhD

Roundtable Discussion: Paclitaxel in PAD: Where We Stand

A panel discussion on the current state of paclitaxel in peripheral artery disease, including how device use has changed, conversations with patients about safety and informed consent, key lessons learned, and how to move forward.

With Daniel J. Bertges, MD; Theodosios Bisdas, MD; Bruce H. Gray, DO, FSCAI, MSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Sabine Steiner, MD; with additional commentary by Jos C. van den Berg, MD, PhD

Trends in Amputation Prevention

By Jos C. van den Berg, MD, PhD

Evolving PAD Approaches

By Peter A. Schneider, MD

Real-World Lower Extremity Revascularization Strategies

By Kumar Madassery, MD, FSIR

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

Surveying the CLI Landscape

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD

Leveling Up in Limb Preservation

By Jos C. van den Berg, MD, PhD